These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2130925)

  • 61. Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A.
    Matsuda M; Saeki E; Kasamatsu A; Nakamikawa C; Manabe S; Samejima Y
    Thromb Res; 1985 Feb; 37(3):379-90. PubMed ID: 3992527
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R.
    Bolliger-Stucki B; Lord ST; Furlan M
    Blood; 2001 Jul; 98(2):351-7. PubMed ID: 11435303
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A polymorphism at B beta 448 of fibrinogen identified during structural studies of fibrinogen Baltimore II.
    Schmelzer CH; Ebert RF; Bell WR
    Thromb Res; 1988 Oct; 52(2):173-7. PubMed ID: 3194892
    [No Abstract]   [Full Text] [Related]  

  • 64. Fibrinogen Baltimore II: congenital hypodysfibrinogenemia with delayed release of fibrinopeptide B and decreased rate of fibrinogen synthesis.
    Ebert RF; Bell WR
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7318-22. PubMed ID: 6580646
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fibrinogen Matsumoto II: gamma 308 Asn-->Lys (AAT-->AAG) mutation associated with bleeding tendency.
    Okumura N; Furihata K; Terasawa F; Ishikawa S; Ueno I; Katsuyama T
    Br J Haematol; 1996 Sep; 94(3):526-8. PubMed ID: 8790154
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fibrinogen Seattle releases half the normal amount of fibrinopeptide B.
    Branson HE; Schmer G; Theodor I; Pirkle H
    Acta Haematol; 1983; 70(4):257-63. PubMed ID: 6414212
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fibrinogen Manchester. Detection of a heterozygous phenotype in the intraplatelet pool.
    Southan C; Lane DA; Knight I; Ireland H; Bottomley J
    Biochem J; 1985 Aug; 229(3):723-30. PubMed ID: 4052020
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fibrinogen Claro--another dysfunctional fibrinogen variant with gamma 275 arginine-->histidine substitution.
    Steinmann C; Jungo M; Beck EA; Lämmle B; Furlan M
    Thromb Res; 1996 Jan; 81(1):145-50. PubMed ID: 8747529
    [No Abstract]   [Full Text] [Related]  

  • 69. Characterization of fibrinogen New York 1. A dysfunctional fibrinogen with a deletion of B beta(9-72) corresponding exactly to exon 2 of the gene.
    Liu CY; Koehn JA; Morgan FJ
    J Biol Chem; 1985 Apr; 260(7):4390-6. PubMed ID: 3156856
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fibrinogen Kyoto II, a new congenitally abnormal molecule, characterized by the replacement of A alpha proline-18 by leucine.
    Yoshida N; Okuma M; Hirata H; Matsuda M; Yamazumi K; Asakura S
    Blood; 1991 Jul; 78(1):149-53. PubMed ID: 2070049
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A.
    Casini A; De Maistre E; Casini-Stuppi V; Fontana P; Neerman-Arbez M; de Moerloose P
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):280-2. PubMed ID: 24389539
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fibrinogens Kawaguchi and Osaka: an amino acid substitution of A alpha arginine-16 to cysteine which forms an extra interchain disulfide bridge between the two A alpha chains.
    Miyata T; Terukina S; Matsuda M; Kasamatsu A; Takeda Y; Murakami T; Iwanaga S
    J Biochem; 1987 Jul; 102(1):93-101. PubMed ID: 3667568
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An abnormal fibrinogen with delayed fibrinopeptide A release.
    Lane DA; VanRoss M; Kakkar VV; Bottomley KJ; Dhir K; Holt LP; MacIver JE
    Br J Haematol; 1980 Sep; 46(1):89-98. PubMed ID: 7426452
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Thrombin hydrolysis of an N-terminal peptide from fibrinogen Lille: kinetic and NMR studies.
    Zheng Z; Ashton RW; Ni F; Scheraga HA
    Biochemistry; 1992 May; 31(18):4426-31. PubMed ID: 1581297
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Substitution (γ335Trp→Arg) in fibrinogen Fremantle causes diminished γ chain expression and increased sialic acid content.
    Brennan SO; Davis RL
    Thromb Haemost; 2010 Dec; 104(6):1274-6. PubMed ID: 20838743
    [No Abstract]   [Full Text] [Related]  

  • 76. Abnormal fibrinogens IJmuiden (B beta Arg14----Cys) and Nijmegen (B beta Arg44----Cys) form disulfide-linked fibrinogen-albumin complexes.
    Koopman J; Haverkate F; Grimbergen J; Engesser L; Nováková I; Kerst AF; Lord ST
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3478-82. PubMed ID: 1565641
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Studies of the structure of canine fibrinogen.
    Birken S; Wilner GD; Canfield RE
    Thromb Res; 1975 Oct; 7(4):599-610. PubMed ID: 1198547
    [No Abstract]   [Full Text] [Related]  

  • 78. Fibrinogen Lima. A new dysfibrinogenaemia with a high-molecular-weight alpha-chain and effective polymerization.
    Arocha-Piñango CL; Rodriguez S; Nagy H; Perez Requejo JL
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):561-5. PubMed ID: 2133234
    [TBL] [Abstract][Full Text] [Related]  

  • 79. On the identity of fibrin(ogen) oligomers appearing during fibrin polymerization.
    Henschen A
    Adv Exp Med Biol; 1990; 281():49-53. PubMed ID: 2102625
    [No Abstract]   [Full Text] [Related]  

  • 80. The impaired polymerization of fibrinogen Longmont (Bbeta166Arg-->Cys) is not improved by removal of disulfide-linked dimers from a mixture of dimers and cysteine-linked monomers.
    Lounes KC; Lefkowitz JB; Henschen-Edman AH; Coates AI; Hantgan RR; Lord ST
    Blood; 2001 Aug; 98(3):661-6. PubMed ID: 11468164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.